High-grade B-cell Lymphoma (HGBL)

Explore clinical trials studying High-grade B-cell Lymphoma (HGBL). Study availability and eligibility vary by location and protocol.

3 public trials 2 recruiting studies

Refine in advanced search Browse all conditions

High-grade B-cell Lymphoma (HGBL) trial results

Recruiting

NCT07197307

Conditions: Aggressive Diffuse Large B-cell Lymphoma, Follicular Lymphoma (FL) Grade 3B, Hemic and Lymphatic Diseases, +12 more
Locations: Universitätsklinikum Münster, Medizinische Klinik A Münster, Germany

Universitaetsklinikum Aachen Aachen, Germany

Universitaetsklinikum Augsburg Augsburg, Germany

Vivantes Netzwerk fuer Gesundheit Berlin, Germany

View all 34 locations

Recruiting

NCT07473167

Conditions: Diffuse Large B-Cell Lymphoma (DLBCL), Hemic and Lymphatic Diseases, High-grade B-cell Lymphoma (HGBL), +14 more
Locations: Seoul National University Hospital Seoul, South Korea

Completed

NCT01742988

Conditions: Double-expressor Lymphoma (DEL), Double-hit Lymphoma (DHL), Hemic and Lymphatic Diseases, +18 more
Locations: USC/Norris Comprehensive Cancer Center Los Angeles, California, United States

Florida Cancer Specialists Sarasota, Florida, United States

Winship Cancer Institute, Emory University Atlanta, Georgia, United States

University of Chicago Medicine Chicago, Illinois, United States